Parametric Portfolio Associates’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Parametric Portfolio Associates’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$232K	Buy	+930	New	+$147K	﹤0.01%	3384

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's EIGR Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2022: 930 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #3384 among its holdings.

95 funds tracked by Wall St. Rank hold EIGR as of Q1 2022.

Parametric Portfolio Associates held 930 shares of Eiger BioPharmaceuticals, Inc. worth $232K as of Q1 2022.
Eiger BioPharmaceuticals, Inc. was a new Parametric Portfolio Associates position in Q1 2022.
Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3384 holding.
95 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.